An Open-Label Evaluation of Safety of the Fentanyl Iontophoretic Transdermal System (40mcg) for Management of Acute Post-Operative Pain in Pediatric Patients

This study has been withdrawn prior to enrollment.

( Company decision to withdraw product from the market and terminate development initiatives due to potential device failures. )

Study NCT00666393 Information provided by Alza Corporation, DE, USA

First Received: April 22, 2008 Last Updated: April 26, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	December 2010
Estimated Primary Completion Date:	September 2010 (Final data collection date for primary outcome measure)